Author

C. Bulai-Livideanu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:imaging· 1 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Brignier· 1 shared A. Maria· 1 shared A. Ouedrani· 1 shared A.-F. Collange· 1 shared B. Chaput· 1 shared C. Bodemere-Skandalis· 1 shared C. GAUDY· 1 shared C. Gourguechon· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Brignier

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivJan 13, 2023

3-D deconvolution of human skin immune architecture with Multiplex Annotated Tissue Imaging System (MANTIS)

M. Scholaert, R. Houmadi, J. Martin…·N. Gaudenzio

This paper introduces MANTIS, a tool for 3-D deconvolution of human skin immune architecture, revealing common immune features in severe skin conditions.

DOI 10.1126/sciadv.adf9491

humanimaging

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 1, 2021

Absence of severe COVID-19 in patients with clonal mast cells activation disorders: effective anti-SARS-CoV-2 immune response.

J. Rossignol, A. Ouedrani, C. Bulai-Livideanu…·Mania

The paper investigates the immune response in patients with clonal mast cells activation disorders (cMCADs) during SARS-CoV-2 infection and finds no severe COVID-19 cases and robust anti-viral immunity.

DOI 10.1101/2021.09.01.458516

humanproteomics

𝕏 PostBluesky